Looking to buy AMP shares? Here's the latest blow to the company's major divestment

The planned Collimate Capital sale is facing regulatory delays.

| More on:
Disappointed woman at the falling share price with her hand oh her had.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • AMP revealed the company's planned Collimate Capital sales are facing regulatory delays this morning
  • As a result, the businesses will miss their targeted November completion 
  • The AMP share price has joined the broader ASX 200 in the red today, falling 0.8% to $1.26 at the time of writing

The AMP Ltd (ASX: AMP) share price is in the red on Tuesday amid potentially disappointing news for those invested in the company.

The financials giant revealed the much-anticipated sale of its Collimate Capital businesses – announced more than six months ago – won't meet a November deadline.

At the time of writing, the AMP share price is 0.79% lower at $1.26. For comparison, the S&P/ASX 200 Index (ASX: XJO) has fallen 0.19% this morning.

Let's take a closer look at the latest on the company's major divestment.

Collimate Capital sales face regulatory delays

The AMP share price is sliding today amid the release of an update on its planned sale of Collimate Capital.

As the company previously announced, Dexus Property Group (ASX: DXS) will take on the business' domestic infrastructure equity and real estate leg, while DigitalBridge will take on its international infrastructure equity segment.

The sales were previously expected to complete in September and November, respectively. Sadly, that's now off the cards.

In a non-price-sensitive release today, AMP said "significant progress" has been made towards the sales' conditions. However, regulatory processes are ongoing. That means the sales won't be completed this month. AMP continued:

All parties are working constructively together towards completion, and we will update the market on the likely completion dates for both transactions as these approvals progress.

Both sales are conditional on regulatory approvals and various other consents. The sale to Dexus also requires approval from regulators in China due to AMP's interest in China Life AMP Asset Management.

Together, the sales will bring $712 million in upfront cash payments. AMP intends to return most of the proceeds to shareholders.

Dexus might also be liable for up to $20 million in earn-outs. That's down from a potential $300 million, mainly due to the loss of control of the AMP Capital Retail Trust and the AMP Capital Wholesale Office Fund.

The maximum potential earn-out for the international infrastructure business is $180 million.

AMP share price snapshot

This year has been good to the AMP share price. It lifted to an 18-month high of $1.30 on Monday.

It has gained 26% year to date and 9% since this time last year. Though, the stock is still trading for 75% less than it was in November 2017.

For comparison, the ASX 200 has fallen 6% in 2022 so far and 5% over the last 12 months.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

A woman presenting company news to investors looks back at the camera and smiles.
Financial Shares

AMP shares on radar as M&A spotlight shines bright

The stock has rallied hard in 2024.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Financial Shares

Are IAG shares still a buy for dividends at a 5-year high?

Here's my take on IAG's place in an income portfolio today.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Financial Shares

After ResMed's 60% rise, this investor is now bullish on the 'most hated' ASX stock

Sometimes it pays to be a contrarian.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
International Stock News

Which ASX small-cap stock is leaping 13% by doubling down on access to cash

This expands its reach in India.

Read more »

A group of business people pump the air and cheer.
Mergers & Acquisitions

This ASX small-cap stock is exploding 75% on takeover news!

The takeover premium is large.

Read more »

Two brokers analysing stocks.
Broker Notes

Don't miss these changes to broker ratings on ASX shares

The verdicts are in.

Read more »

private health insurance diagram.
Financial Shares

Why did the NIB share price just hit a 3-year low?

Investors reacted negatively to an announcement from the private health insurer.

Read more »

A woman sits on a chair smiling as she shops online.
Financial Shares

Zip share price hits yet another 52-week high. Is it still undervalued?

Is Zip on the cusp of an earnings explosion?

Read more »